DUBLIN--(BUSINESS WIRE)--The "Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
Global oral antibiotics market will reach $26.67 billion by 2030, growing by 4.0% annually over 2020-2030 driven by rising complications associated with COVID-19 epidemic, development of innovative antibiotics, and growing healthcare expenditure.
Highlighted with 89 tables and 97 figures, this 187-page report Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global oral antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global oral antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global oral antibiotics market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Topics Covered:
1.1 Industry Definition and Research Scope
1.2 Research Methodology
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's five Forces Analysis
3 Segmentation of Global Market by Drug Class
3.1 Market Overview by Drug Class
3.9 Other Drug Classes
4 Segmentation of Global Market by Action Mechanism
4.1 Market Overview by Action Mechanism
4.2 Cell Wall Synthesis Inhibitors
4.3 Mycolic Acid Inhibitors
4.4 RNA Synthesis Inhibitors
4.5 DNA Synthesis Inhibitors
4.6 Protein Synthesis Inhibitors
4.7 Other Mechanisms
5 Segmentation of Global Market by Drug Origin
5.1 Market Overview by Drug Origin
5.2 Natural Antibiotics
5.3 Semi-synthetic Antibiotics
5.4 Synthetic Antibiotics
6 Segmentation of Global Market by Activity Spectrum
6.1 Market Overview by Activity Spectrum
6.2 Broad-spectrum Antibiotics
6.3 Narrow-spectrum Antibiotics
7 Segmentation of Global Market by Application
7.1 Market Overview by Application
7.2 Urinary Tract Infections (UTIS)
7.3 Dental Infections
7.3.1 Monotherapies for Dental Infections
7.3.2 Combined Therapies for Dental Infections
7.4 Respiratory Tract Infections (RTIS)
7.4.1 Upper Respiratory Tract Infections (URTI)
7.4.2 Lower Respiratory Tract Infections (LRTIs)
7.5 Other Applications
8 Segmentation of Global Market by Drug Type
8.1 Market Overview by Drug Type
8.2 Brand Antibiotics
8.3 Generic Antibiotics
9 Segmentation of Global Market by Region
10 Competitive Landscape
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
- Abbott Laboratories
- Astellas Pharma
- AstraZeneca Plc
- Bayer AG
- Bristol Myers Squibb Company
- Cipla Inc.
- Dr. Reddy's Laboratories Ltd.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)
- Mayne Pharma Group Ltd.
- MELINTA THERAPEUTICS, INC.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
11 Investing in Global Market: Risk Assessment and Management
11.1 Risk Evaluation of Global Market
11.2 Critical Success Factors (CSFs)
For more information about this report visit https://www.researchandmarkets.com/r/7oomo8